Atlas Trials

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

Clinical trial NCT05346276 · COMPLETED

Trial details

NCT number
NCT05346276
Sponsor
The First Affiliated Hospital of Xiamen University
Status
COMPLETED
Study type
OBSERVATIONAL
PET/CThLAG-3TUMOR
Start date
2022-10-10
Primary completion
2024-12-13
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.